Enliven Therapeutics
ELVN
#5377
Rank
โ‚ฌ1.05 B
Marketcap
21,62ย โ‚ฌ
Share price
-1.75%
Change (1 day)
60.48%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ16.37 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ16.37 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ23.48 M-84.27%
2022-12-31โ‚ฌ0.14 B8.22%
2021-12-31โ‚ฌ0.13 B12.13%
2020-12-31โ‚ฌ0.12 B